Obi L Griffith
Overview
Explore the profile of Obi L Griffith including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
158
Citations
10791
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen H, Ferguson C, Mitchell D, Risch I, Titus A, Paulo J, et al.
Cell Rep
. 2025 Jan;
44(2):115231.
PMID: 39862434
Mutation or deletion of the deubiquitinase USP7 causes Hao-Fountain syndrome (HAFOUS), which is characterized by speech delay, intellectual disability, and aggressive behavior and highlights important unknown roles of USP7 in...
2.
Myers C, Kumar R, Pilgram L, Bonomi L, Thomas M, Griffith O, et al.
Clin Chem
. 2025 Jan;
71(1):10-17.
PMID: 39749498
No abstract available.
3.
Xia H, Hoang M, Schmidt E, Kiwala S, McMichael J, Skidmore Z, et al.
Genome Med
. 2024 Nov;
16(1):132.
PMID: 39538339
Background: Neoantigen-targeting therapies including personalized vaccines have shown promise in the treatment of cancers, particularly when used in combination with checkpoint blockade therapy. At least 100 clinical trials involving these...
4.
Gomez F, Danos A, Del Fiol G, Madabhushi A, Tiwari P, McMichael J, et al.
Cancer Discov
. 2024 Oct;
14(10):1774-1778.
PMID: 39363742
People diagnosed with cancer and their formal and informal caregivers are increasingly faced with a deluge of complex information, thanks to rapid advancements in the type and volume of diagnostic,...
5.
Xia H, Hoang M, Schmidt E, Kiwala S, McMichael J, Skidmore Z, et al.
ArXiv
. 2024 Jul;
PMID: 38947921
Background: Neoantigen targeting therapies including personalized vaccines have shown promise in the treatment of cancers, particularly when used in combination with checkpoint blockade therapy. At least 100 clinical trials involving...
6.
Foltz J, Tran J, Wong P, Fan C, Schmidt E, Fisk B, et al.
Sci Immunol
. 2024 Jun;
9(96):eadk4893.
PMID: 38941480
Activation of natural killer (NK) cells with the cytokines interleukin-12 (IL-12), IL-15, and IL-18 induces their differentiation into memory-like (ML) NK cells; however, the underlying epigenetic and transcriptional mechanisms are...
7.
Yoon C, Nam C, Kim T, Lee J, Kim R, Yi K, et al.
HGG Adv
. 2024 May;
5(3):100301.
PMID: 38773773
While most dizygotic twins have a dichorionic placenta, rare cases of dizygotic twins with a monochorionic placenta have been reported. The monochorionic placenta in dizygotic twins allows in utero exchange...
8.
Ramirez C, Becker-Hapak M, Singhal K, Russler-Germain D, Frenkel F, Barnell E, et al.
Blood Adv
. 2024 May;
8(15):4035-4049.
PMID: 38713894
Personalized cancer vaccines designed to target neoantigens represent a promising new treatment paradigm in oncology. In contrast to classical idiotype vaccines, we hypothesized that "polyvalent" vaccines could be engineered for...
9.
Hoang M, Skidmore Z, Rindt H, Chu S, Fisk B, Foltz J, et al.
Commun Biol
. 2024 Apr;
7(1):484.
PMID: 38649520
Spontaneous cancers in companion dogs are robust models of human disease. Tracking tumor-specific immune responses in these models requires reagents to perform species-specific single cell T cell receptor sequencing (scTCRseq)....
10.
Waters M, Inkman M, Jayachandran K, Kowalchuk R, Robinson C, Schwarz J, et al.
Patterns (N Y)
. 2024 Feb;
5(2):100910.
PMID: 38370125
Big genomic data and artificial intelligence (AI) are ushering in an era of precision medicine, providing opportunities to study previously under-represented subtypes and rare diseases rather than categorize them as...